Stock 300942 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Shenzhen Bioeasy Biotechnology Co., Ltd.

Equities

300942

CNE100004C78

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
7.35 CNY +1.52% Intraday chart for Shenzhen Bioeasy Biotechnology Co., Ltd. +0.55% -37.13%
May. 14 Wang Tianyi completed the acquisition of 6.59% stake in Shenzhen Bioeasy Biotechnology Co., Ltd. from Bioeasy Venture Capital Co., Ltd., Zhu Hai and Shenzhen Yidarui Management Consulting Partnership Enterprise (Limited Partnership). CI
Apr. 25 Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wang Tianyi completed the acquisition of 6.59% stake in Shenzhen Bioeasy Biotechnology Co., Ltd. from Bioeasy Venture Capital Co., Ltd., Zhu Hai and Shenzhen Yidarui Management Consulting Partnership Enterprise (Limited Partnership).
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Announces Executive Appointments
CI
Certain A Shares of Shenzhen Bioeasy Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-FEB-2024.
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Bioeasy Joins Other Biotech Firms in Requesting to Cancel COVID-19 Test Kits
MT
Shenzhen Bioeasy Biotechnology Approves Cash Dividend for 2022, Payable on 31 May 2023
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Proposes Final Dividend for 2022
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shenzhen Bioeasy Biotechnology Unit Gets Registration Certificates for Medical Devices
MT
Shenzhen Bioeasy Biotechnology Co., Ltd.(XSEC:300942) added to S&P Global BMI Index
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Announces Executive Appointments
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Approves Final Cash Dividend for the Year 2021, Payable on 30 May 2022
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Proposes Final Cash Dividend for the Year 2021
CI
Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300942 Stock
  4. News Shenzhen Bioeasy Biotechnology Co., Ltd.